
词语导航
基本信息
词语:腹水的
繁体:腹水的
拼音:fù shuǐ de
英语翻译
【医】 ascitic
分词翻译
腹水的英语翻译:
ascites
【医】 abdominal dropsy; ascites; ascitic Fluid; dropsy of belly; hydrogaster
hydroperitoneum; hydroperitonia; hydrops abdominis; peritoneal dropsy
seroperitoneum
翻译例句
1. 胆固醇含量鉴别良恶性腹水的意义。
Significance of cholesterol content for differentiating the benign and malignant ascites.
2. 探讨肝硬化顽固性腹水的治疗方法。
To study the treatment method of the obstinate cirrhosis ascites.
3. 肝硬化腹水的肝,机械阻塞或心脏衰竭。
Ascites due to cirrhosis of the liver, mechanical obstruction or cardiac failure.
4. 目的:观察微波治疗肝硬化腹水的疗效。
Objective: to observe the effect of microwave treatment in hepatocirrhosis.
5. 介绍许鑫梅教授治疗肝硬化腹水的经验。
Prof. Xu s experience on the treatment of ascites dueu to cirrhosis was presented.
6. 目的提高对胰性腹水的认识和诊治水平。
Objective To discuss diagnosis and treatment of pancreatic ascites.
7. 目的:观察蜂实饮治疗肝硬变腹水的疗效。
Objective: To analyze clinical effect of Fengshi decoction on liver cirrhotic ascites.
8. 方法:分析27例不明原因的腹水的检查结果。
Methods: Analyzes 27 example unknown causes ascots check result.
9. 提示了在利水中药中泽泻是治疗腹水的有效药物。
It is suggested that Rhizoma Alismatis is an effective drug on the treatment of ascites.
10. 目的:观察中药药膳治疗肝硬化腹水的临床效果。
Objective:To observe the clinical effect of medicated diet of TCM on cirrhosis ascites.
11. 目的:探讨中西药联合治疗肝硬化腹水的临床疗效。
Objective Purpose: in the study western medicine consociation treatment hepatocirrhosis ascites clinical curative effect.
12. 目的观察消胀利水合剂治疗肝硬化腹水的临床效果。
Objective to observe clinical effects of ascites due to cirrhosis treated with Xiao Zhang li Shui mixture.
13. 引起肝病患者水、盐潴留和腹水的原因可能不止一个。
There are probably several factors responsible for water and salt retention and ascites in hepatic disease.
14. 目的:探讨肝硬变顽固性腹水的治疗及影响疗效的因素。
Aim: to investigate the therapeutic effect of intractable ascites of cirrhosis and closely related factors.
15. 目的探讨自拟鼓胀方对肝硬化(LC)腹水的治疗作用。
Objective To study the therapeutic effects of self-drafted Guzhang prescription in treatment of patients of liver cirrhosis (LC) and ascites.
16. 目的观察腹水浓缩静脉回输治疗难治性肝硬化腹水的疗效。
Objective to observe the therapeutic effects of ascitic concentration and venous re-transfusion on refractory ascites due to cirrhosis.
17. 目的:探讨复方中药制剂治疗顽固性肝硬化腹水的临床疗效。
AIMS: to study clinical efficacy of Chinese herbs in treating refractory ascites in cirrhotic patients.
18. 目的:研究扶正法结合腹腔化疗对小鼠恶性腹水的干预作用。
Objective: to study the intervention on malignant ascites with method of Fuzheng combined intraperitoneal chemotherapy.
19. 腹水的膨隆(图148-3)有时难以同躯干性肥胖鉴别。
Distention from ascites (Fig. 148-3) is sometimes difficult to differentiate from truncal obesity.
20. 目的探讨连续密闭式腹水直接静脉回输治疗顽固性腹水的疗效。
Objective To study the effect of treatment intractable ascites by ascites direct veinous reinfusion closed continuously.
21. 目的探讨腹水超滤浓缩腹腔回输治疗顽固性肝硬化腹水的效果。
Objective To explore the therapeutic effect of ascites superfilter concentration and reinfusion method on hepatic cirrhosis patients with refractory ascites.
22. 前言:目的:探讨并整理名老中医韩哲仙治疗肝硬化腹水的经验。
Objective: to investigate and sort out the experience of an aged TCM. doctor of Hanzhexian in treating ascites due to liver cirrhosis.
23. 目的:观察腹腔热灌注化疗联合热疗治疗恶性腹水的疗效及其副反应。
Objective: To evaluate the effects and toxicities of the chemotherapeutic hyperthermic intraperitoneal perfusion(CHIP) combined with hyperthermia for the treatment of malignant ascites.
24. 大多数肝硬化腹水的患者凝血酶原时间延长并有一定程度的血小板减少。
The majority of patients with ascites due to cirrhosis have prolongation of the prothrombin time and some degree of thrombocytopenia.
25. 目的观察腹水超滤浓缩腹腔回输治疗肝硬变顽固性腹水的疗效与安全性。
Objective To observe the efficacy and safety of ultrafiltration and peritoneal reinfusion of ascites to treat refractory cirrhotic ascites.
26. 检测腺苷脱氨酶对结核性腹水的敏感性为88.9%,特异性为100%。
The sensitivity of identifying of tuberculous ascites by measurement of ADA was 88.9% and the specificity was 100%.
27. 研究腹水超滤浓缩腹腔回输治疗难治性腹水的临床疗效并进行经济学评价。
To investigate the therapeutic efficacy and economic analysis of ultrafilter concentration in refractory ascites.
28. 原发性腹膜炎是肝硬变腹水的严重并发症,多见于有严重肝病背景的病人。
Primary peritonitis(PP) is a serious complication of cirrhotic ascites, arising most frenquently in patients with advanced liver disease.
29. 目的:探讨血清腹水白蛋白梯度(SAAG)诊断非门脉高压性腹水的价值。
Objective: To evaluate the value of SAAG in diagnosis of non portal hypertension ascites.
30. 目的:探讨血清腹水白蛋白梯度(SAAG)诊断非门脉高压性腹水的价值。wWW.WenTiYi.cOM
Objective: To evaluate the value of SAAG in diagnosis of non portal hypertension ascites.
版权声明:问题易所有作品(图文、音视频)均来源网络,版权归原创作者所有,与本站立场无关,如不慎侵犯了你的权益,请联系我们告知,我们将做删除处理!
